Company CVAbout Kabra Drugs Ltd 
Kabra Drugs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P.
Company Coordinates
Company Details
270 Shastri Market Indore , Indore Madhya Pradesh : 452007
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
None
Highest Public shareholder
Kuniamuthur Nanjappan Anand (2.78%)
Individual Investors Holdings
91.43%
Board of Directors
Management
Designation
Remuneration
B V Anatha Kumar
Whole Time Director & CFO
0
R Muralidharan
Independent Director
0
Ananthkumar Shilpa
Independent Director
0
Churchil Durai M Jebastine
Independent Director
0
Nidhi Bhaskar
Company Secretary
0
KUNIAMUTHUR NANJAPPAN ANAND
Additional Director
0
Monika Sanwal
Company Sec. & Compli. Officer
0
A Anitha
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Anaesthetic
1.08
43.13%
Injection/Eye/Ear Drop
0.64
25.68%
Soft Gel Capsule
0.38
15.16%
Anaesthetic
Anaesthetic
Injection/Eye/Ear Drop
Injection/Eye/Ear Drop
Soft Gel Capsule
Soft Gel Capsule
Stock DNARevenue and Profits:
Net Sales:
30 Cr
(Quarterly Results - Dec 2025)
Net Profit:
3 Cr
Pharmaceuticals & Biotechnology
INR 71 Cr (Micro Cap)
NA (Loss Making)
32
0.00%
-0.43
-4.19%
2.77
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
